These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12891308)

  • 1. [Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension].
    Karpov IuA; Deev AD;
    Kardiologiia; 2003; 43(6):28-32. PubMed ID: 12891308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies.
    Yener G; Aran S; Bahceci M; Ozdemir K; Gultekin F; Lowe W
    Clin Drug Investig; 2007; 27(9):613-22. PubMed ID: 17705570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of quinapril in the elderly hypertensive patient.
    Forette B; Koen R; Vicaut E
    Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.
    Mokwe E; Ohmit SE; Nasser SA; Shafi T; Saunders E; Crook E; Dudley A; Flack JM
    Hypertension; 2004 Jun; 43(6):1202-7. PubMed ID: 15117912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
    Kloner RA; Neutel J; Roth EM; Weiss R; Weinberger MH; Thakker KM; Schwartz B; Shi H; Gregg AM;
    Ann Pharmacother; 2008 Nov; 42(11):1552-62. PubMed ID: 18827176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor.
    Okuguchi T; Osanai T; Fujiwara N; Kato T; Metoki N; Konta Y; Okumura K
    Am J Hypertens; 2002 Nov; 15(11):998-1002. PubMed ID: 12441222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
    Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
    Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the effect of angiotensin converting enzyme inhibitor moexipril on the functional state of vascular wall in patients with I - III degree arterial hypertension].
    Ageev FT; Seredenina EM; Orlova IaA; Kulev BD; Plisiuk AG; Chernina GV; Patrusheva IF
    Kardiologiia; 2007; 47(8):44-8. PubMed ID: 18260911
    [No Abstract]   [Full Text] [Related]  

  • 14. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
    Schnaper HW
    Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.